Differential diagnostic search for hypereosinophilic syndrome
https://doi.org/10.17650/1818-8346-2025-20-3-47-51
Abstract
Idiopathic hypereosinophilic syndrome is characterized by a persistent increase in serum eosinophil counts >1.5 × 109 / L for 4 weeks and the absence of any clinical, laboratory and instrumental data suggesting the etiology of this phenomenon. It is not always possible to confirm the reactive nature of eosinophilia or identify clonal disease. The article presents a clinical case of differential diagnostic search for the cause of hypereosinophilia in a patient.
About the Authors
A. S. Buzuk
City Hospital No. 26
Russian Federation
Russian Federation
2 Kostyushko St., Saint Petersburg 196247
E. V. Chernova
City Hospital No. 26
Russian Federation
Russian Federation
2 Kostyushko St., Saint Petersburg 196247
A. V. Koloskov
City Hospital No. 26
Russian Federation
Russian Federation
Kostyushko St., Saint Petersburg 196247
V. N. Marchenko
I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg 197022
References
1. Kanuru S., Sapra A. Eosinophilia. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
2. Kovrigina A.M., Melikyan A.I., Nemchenko I.S. et al. Myeloproliferative diseases (MPD) associated with eosinophilia. Clinical guidelines. Moscow: Natsionalnoe gematologicheskoe obshchestvo, 2018. (In Russ.).
3. Shomali W., Gotlib J. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. Am J Hematol 2024;99(5):946–68. DOI: 10.1002/ajh.27287
4. Klion A.D. Approach to the patient with suspected hypereosinophilic syndrome. Hematology Am Soc Hematol Educ Program 2022;2022(1):47–54. DOI: 10.1182/hematology.2022000367
5. Ruan G.J., Smith C.J., Day C. et al. A population-based study of chronic eosinophilic leukemia-not otherwise specified in the United States. Am J Hematol 2020;95(10):E257–60. DOI: 10.1002/ajh.25906
6. Valent P., Klion A.D., Roufosse F. et al. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes. Allergy 2023;78(1):47–59. DOI: 10.1111/all.15544
7. Pulsoni A., Iacobelli S., Bernardi M. et al. M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience. Haematologica 2008;93(7):1025–32. DOI: 10.3324/haematol.11889
8. Matsushima T., Handa H., Yokohama A. et al. Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia. Blood 2003;101(9):3386–90. DOI: 10.1182/blood-2002-03-0947
9. Lepretre S. Eosinophilia in leukemias: a probable leukemic clone. Haematologica 2022;87:785–6.
10. Mikhaylova N.B., Afanas’ev B.V. Сlonal eosinophilia. Klinicheskaya onkogematologiya = Clinical Oncohematology 2009;2(1):1–10. (In Russ.).
Review
For citations:
Buzuk A.S., Chernova E.V., Koloskov A.V., Marchenko V.N. Differential diagnostic search for hypereosinophilic syndrome. Oncohematology. 2025;20(3):47-51. (In Russ.) https://doi.org/10.17650/1818-8346-2025-20-3-47-51
Views:
4
Email this article 